Stockreport

Private equity firms who have a significant stake must be disappointed along with institutions after Eliem Therapeutics, Inc.'s (NASDAQ:ELYM) market cap dropped by US$231m [Yahoo! Finance]

Eliem Therapeutics, Inc  (ELYM) 
PDF Significant control over Eliem Therapeutics by private equity firms implies that the general public has more power to influence management and governance-related decisi [Read more]